Internal Medicine, Infectious Disease · Indianapolis, IN
NPI
1598261364
Since 2018
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1400 N Ritter Ave Ste 241
Indianapolis, IN, 46219
Phone (317) 621-1690
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
571 services
Medicare patients, 2024
188
Average age 70
Drug cost, 2024
$177K
342 prescriptions
Company payments, 2024
$150
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kanupriya Gulati was code 99232 (hospital e&m - subsequent), 422 times for 154 patients. In total Kanupriya Gulati billed 571 services in 12 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 422 | 154 | $57.63 | $24K |
| 99222 Hospital E&M - Initial | Facility | 84 | 75 | $93.50 | $7,854 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $127.74 | $2,683 |
By year: 2023 $7,318 for 104 services; 2024 $38K for 571 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kanupriya Gulati prescribed most often to Medicare patients was Ampicillin Sodium, with 29 prescriptions and refills. In total Kanupriya Gulati wrote 342 Medicare prescriptions that cost $177K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ampicillin Sodium Generic | 29 | 29 | Under 11 | $8,255 |
| Ceftriaxone Ceftriaxone Sodium | 25 | 25 | Under 11 | $1,100 |
| Cephalexin Generic | 24 | 24 | Under 11 | $293 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 22 | 22 | 19 | $240 |
| Cefazolin Sodium Generic | 20 | 20 | Under 11 | $1,717 |
| Vancomycin Hcl Generic | 13 | 13 | Under 11 | $726 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 23 | Under 11 | $108 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 11 | 11 | Under 11 | $2,789 |
| Tivicay Dolutegravir Sodium | 11 | 11 | Under 11 | $24K |
| Edurant Rilpivirine Hcl | 11 | 11 | Under 11 | $16K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 11 | 11 | Under 11 | $38K |
Brand drugs: 62 claims; generic drugs: 280 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kanupriya Gulati $150 ($150 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.